ABER FUTURA Series In-line Viable Cell Concentration Analyzer
| Origin | UK |
|---|---|
| Manufacturer Type | Authorized Distributor |
| Origin Category | Imported |
| Model | ABER FUTURA |
| Pricing | Upon Request |
| Measurement Speed | Real-time |
| Measurable Cell Concentration Range | Yeast (6 µm): 10⁶–10¹⁰ cells/mL |
| Bacteria (1 µm) | 10⁹–10¹³ cells/mL |
| Animal Cells (12 µm) | 10⁵–10⁹ cells/mL |
| Plant Cells (50 µm) | 10³–10⁷ cells/mL |
| Sample Handling | Insertion-type in-line probe |
| Throughput | Continuous in-line monitoring |
| Detectable Cell Types | Plant cells, animal cells, microorganisms, bacteria |
Overview
The ABER FUTURA Series In-line Viable Cell Concentration Analyzer is an engineered solution for real-time, non-invasive quantification of viable biomass in bioreactors and fermentation systems. Based on dielectric spectroscopy—specifically the measurement of cell membrane capacitance and bulk medium conductivity—the FUTURA exploits the intrinsic electrical properties of intact biological cells. When subjected to an alternating electric field, living cells with intact plasma membranes behave as microscopic capacitors: their lipid bilayer acts as a dielectric barrier, enabling charge separation across the membrane. The resulting permittivity shift is directly proportional to the volume fraction of viable, membrane-intact cells in suspension. This principle enables label-free, continuous monitoring without sampling, staining, or cell lysis—critical for maintaining sterility and process integrity in GMP-compliant upstream bioprocessing.
Key Features
- Real-time, in-line measurement via sterile-insertion probe—no manual sampling or offline analysis required
- Dual-parameter output: viable cell concentration (cells/mL or g/L, calibrated per cell type) and medium conductivity (mS/cm)
- Wide dynamic range across diverse cell morphologies: validated for bacteria (1 µm), yeast (6 µm), mammalian cells (12 µm), and plant cells (up to 50 µm)
- No consumables, no reagents, no optical components—minimizes maintenance and operational cost of ownership
- IP68-rated stainless-steel probe housing compatible with CIP/SIP protocols and ASME BPE surface finish standards
- Configurable analog (4–20 mA) and digital (Modbus RTU/TCP, Ethernet/IP) outputs for seamless integration into DCS/SCADA and PAT frameworks
Sample Compatibility & Compliance
The FUTURA analyzer supports direct insertion into stirred-tank bioreactors, perfusion systems, and single-use bags (with appropriate port adapters). It is compatible with common cell culture media—including chemically defined, serum-containing, and high-viscosity formulations—as well as microbial fermentation broths containing antifoams or nutrient supplements. The system meets IEC 61000-6-2 (immunity) and IEC 61000-6-4 (emissions) standards. Its measurement methodology aligns with FDA’s Process Analytical Technology (PAT) initiative and supports data integrity requirements under 21 CFR Part 11 when deployed with compliant software platforms. Calibration traceability follows ISO/IEC 17025 principles, and validation documentation (IQ/OQ/PQ protocols) is available for GxP environments.
Software & Data Management
The FUTURA integrates with ABER’s proprietary BioView™ software suite, which provides real-time visualization, trend logging, alarm configuration, and batch export in CSV or ASTM E1394-compliant formats. All raw capacitance and conductivity data are timestamped and stored with full audit trail functionality—including user login history, parameter changes, and calibration events—to satisfy GLP and GMP record-keeping obligations. Optional OPC UA connectivity enables bidirectional data exchange with MES and LIMS systems. Historical datasets can be exported for multivariate analysis (e.g., PCA, PLS regression) to correlate dielectric signals with offline assays such as viability staining or metabolite HPLC.
Applications
- Monitoring viable cell density during CHO, HEK293, and hybridoma cultivations for monoclonal antibody production
- Tracking bacterial growth kinetics in E. coli and Bacillus expression systems
- Optimizing feeding strategies in perfusion bioreactors by triggering nutrient addition based on real-time biomass thresholds
- Validating sterilization cycles via rapid post-SIP detection of residual viable biomass
- Supporting QbD-based process characterization studies through continuous correlation of dielectric response with critical quality attributes (CQAs)
- Enabling closed-loop control of pH and DO setpoints using biomass-derived feedback signals
FAQ
How does the FUTURA distinguish viable from non-viable cells?
It measures the dielectric dispersion arising specifically from intact plasma membranes; lysed or compromised cells contribute negligibly to the capacitance signal due to loss of transmembrane dielectric contrast.
Can the system be used in high-cell-density perfusion cultures?
Yes—its linear response has been verified up to 10⁸ viable mammalian cells/mL and beyond in pilot-scale perfusion bioreactors equipped with alternating tangential flow (ATF) units.
Is calibration required for each new cell line?
A one-time empirical calibration is recommended per cell type and medium composition to establish the capacitance-to-concentration conversion factor; subsequent runs maintain accuracy without recalibration under stable process conditions.
Does medium conductivity interfere with cell concentration measurements?
No—the instrument applies multi-frequency excitation and employs phase-sensitive demodulation to decouple the β-dispersion (cell-related capacitance) from the α- and γ-dispersions (electrolyte and electrode polarization effects).
What validation support is provided for regulated manufacturing?
ABER supplies comprehensive validation packages including risk assessments (FMEA), test scripts, raw data templates, and electronic signatures compliant with Annex 11 and ALCOA+ principles.
